Sugi Predict

Sugi Predict / Compounds / SCHEMBL20422425

SCHEMBL20422425

SCHEMBL20422425

CC(C)(C)OC(=O)N[C@H](Cc1cc(F)c(O)c(F)c1)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 2/20 0.57
▸ PTPN1 P18031 1/20 0.54
▸ ITGB3 P05106 2/20 0.51
▸ ITGA2B P08514 2/20 0.51
▸ CTSS P25774 9/20 0.50
▸ CTSK P43235 8/20 0.50
▸ CTSB P07858 2/20 0.47
▸ CTSL P07711 1/20 0.47
▸ PPARA Q07869 5/20 0.46
▸ PPARG P37231 4/20 0.46
▸ ITGB1 P05556 1/20 0.45
▸ ITGAV P06756 1/20 0.45
▸ ITGB5 P18084 1/20 0.45
▸ PPARD Q03181 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21623778 1.00 ACE (0.57) ACEPTPN1ITGB3ITGA2BCTSS
SCHEMBL20422427 1.00 ACE (0.57) ACEPTPN1ITGB3ITGA2BCTSS
SCHEMBL23574224 0.92 ACE (0.52) ACEPTPN1ITGB3ITGA2BCTSS
SCHEMBL23574222 0.92 ACE (0.52) ACEPTPN1ITGB3ITGA2BCTSS
SCHEMBL1516491 0.91 ACE (0.58) ACEPTPN1ITGB3ITGA2BCTSS
SCHEMBL21243768 0.91 ACE (0.58) ACEPTPN1ITGB3ITGA2BCTSS
SCHEMBL1246367 0.91 ACE (0.58) ACEPTPN1ITGB3ITGA2BCTSS
SCHEMBL22444999 0.87 ACE (0.55) ACEPTPN1ITGB3ITGA2BCTSS
SCHEMBL16448142 0.87 ACE (0.55) ACEPTPN1ITGB3ITGA2BCTSS
SCHEMBL1448035 0.86 ACE (0.59) ACEPTPN1ITGB3ITGA2BCTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110248939-B Tyrosine amide derivatives as RHO-kinase inhibitors 奇斯药制品公司 2022-05-17 — — CN disclosed
US-10954236-B2 Tyrosine amide derivatives as Rho-Kinase inhibitors CHIESI FARMACEUTICI S.P.A. (IT) 2021-03-23 — — US disclosed
EP-3573987-B1 TYROSINE AMIDE DERIVATIVES AS RHO- KINASE INHIBITORS CHIESI FARM SPA (IT) 2021-03-10 — — EP disclosed
US-20200079774-A1 TYROSINE AMIDE DERIVATIVES AS RHO- KINASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2020-03-12 — — US disclosed
CN-110248939-A tyrosine amide derivatives as RHO-kinase inhibitors 奇斯药制品公司 2019-09-17 — — CN disclosed
US-20180215758-A1 TYROSINE AMIDE DERIVATIVES AS RHO- KINASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2018-08-02 — — US disclosed
WO-2018138293-A1 TYROSINE AMIDE DERIVATIVES AS RHO- KINASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2018-08-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10954236-B2 Tyrosine amide derivatives as Rho-Kinase inhibitors ROCK1, ROCK2, CIT ACE 1109/4885PTPN1 644/4885ITGB3 2624/4885
US-20200079774-A1 TYROSINE AMIDE DERIVATIVES AS RHO- KINASE INHIBITORS ROCK1, ROCK2, CIT ACE 1109/4885PTPN1 644/4885ITGB3 2624/4885
US-20180215758-A1 TYROSINE AMIDE DERIVATIVES AS RHO- KINASE INHIBITORS ROCK1, ROCK2, CIT ACE 1109/4885PTPN1 644/4885ITGB3 2624/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.